A case of antisynthetase syndrome in a rheumatoid arthritis patient with anti-PL-12 antibody following treatment with etanercept
- 11 January 2011
- journal article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 30 (3) , 429-432
Abstract
In our earlier study, we had reported the case of a patient with rheumatoid arthritis (RA), who had anti-Jo-1 antibodies. This patient had received etanercept (ETN) therapy for RA, after which she had developed overt polymyositis (PM). Although various autoimmune phenomena, including lupus-like diseases, vasculitides, or psoriatic skin lesions, are associated with antitumor necrosis factor (TNF) therapy, the development of PM/dermatomyositis (DM) or antisynthetase syndrome following anti-TNF therapy is extremely rare. Here, we report a case of an RA patient with anti-PL-12 antibodies, who received ETN therapy and subsequently developed the antisynthetase syndrome. She recovered when ETN therapy was withdrawn and high-dose corticosteroid was administered. To date, there have been only five reported cases of RA patients with anti-Jo-1 antibodies who developed overt PM/DM following anti-TNF therapy and only one case of antisynthetase syndrome in an RA patient with anti-PL-7 antibodies. Our patients and the abovementioned reports strongly suggest that onset of overt PM/DM or antisynthetase syndrome in RA patients with anti-aminoacyl tRNA synthetase antibodies is associated with anti-TNF therapy.Keywords
This publication has 15 references indexed in Scilit:
- Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literatureClinical Rheumatology, 2010
- Clinical Profile of Anti-PL-12 AutoantibodyChest, 2009
- Autoimmune diseases induced by TNF-targeted therapiesBest Practice & Research Clinical Rheumatology, 2008
- Polymyositis associated with infliximab treatment for rheumatoid arthritisModern Rheumatology, 2006
- Evolution of dermatomyositis during therapy with a tumor necrosis factor α inhibitorArthritis Care & Research, 2006
- Polymyositis associated with infliximab treatment for rheumatoid arthritisRheumatology, 2003
- Humoral aspects of polymyositis/dermatomyositisModern Rheumatology, 2000
- Autoantibodies against alanyl-tRNA synthetase and tRNAAla coexist and are associated with myositis.Journal of Experimental Medicine, 1986
- Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody.Journal of Experimental Medicine, 1984
- Heterogeneity of precipitating antibodies in polymyositis and dermatomyositisArthritis & Rheumatism, 1980